ARCHIVES

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

This article is from The Cancer Letter archive.

Vol. 31 No. 22 | June 3, 2005

Download PDF Visit The Full Archive

Related Articles

NCI CTEP Approved Trials For the Month of September

September 27, 2013

Bypass Budget Is Realistic, Defensible Plan, Broder Says

September 27, 1991

Sandra Horning elected ASCO president-elect.

February 27, 2004

Minnesota Study Aimed At Finding Final Answer On Hemoccult Screening

July 24, 1987

Schmidt’s Doubts Threaten Control Saturation Program

August 22, 1975

OMB Reprogramming Ban Criticized

September 20, 1985